Owens & Minor (NYSE:OMI) Issues FY 2024 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.500-1.530 for the period, compared to the consensus estimate of 1.510. The company issued revenue guidance of $10.7 billion-$10.7 billion, compared to the consensus revenue estimate of $10.7 billion. Owens & Minor also updated its Q4 2024 guidance to 0.520-0.550 EPS.

Analyst Ratings Changes

OMI has been the topic of several recent research reports. UBS Group reduced their price objective on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird cut their target price on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday. Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Finally, Barclays decreased their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $18.50.

Owens & Minor Stock Performance

Shares of OMI traded down $0.15 during trading hours on Wednesday, hitting $8.99. The company had a trading volume of 643,193 shares, compared to its average volume of 871,121. Owens & Minor has a 12 month low of $8.75 and a 12 month high of $28.35. The firm has a market cap of $693.30 million, a price-to-earnings ratio of -13.83, a PEG ratio of 0.40 and a beta of 0.48. The business has a fifty day moving average of $13.69 and a 200-day moving average of $14.24. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter in the previous year, the business posted $0.44 EPS. Owens & Minor’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities analysts anticipate that Owens & Minor will post 1.49 EPS for the current fiscal year.

Insider Buying and Selling at Owens & Minor

In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.62% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.